CRO Vial Highlights Clinical Trial Platform
Recent investments bring clinical trial technology platform to the fore.
Vial, a CRO that was founded in 2020, is growing awareness around its company with a recent influx of funding. Vial was formed with the goal of bringing professionals with clinical trial depth and expertise together with Silicon Valley experts to build a technology platform. This platform features three key areas of clinical trial conduct--site startup, eSource and patient recruitment—each in its own part of the platform.
For more information, please read the full release.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
